Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Classic blood thinner monitored by INR tests. | Twice-daily blood thinner without routine monitoring. |
| Body system | Blood & Clotting | Blood & Clotting |
| Drug class | Vitamin K antagonists | Direct oral anticoagulants |
| Supply | Prescription onlyWHO essential medicine | Prescription only |
| Main uses | Atrial fibrillation stroke prevention, Deep vein thrombosis and pulmonary embolism, Mechanical heart valves | Stroke prevention in atrial fibrillation, Deep vein thrombosis and pulmonary embolism, Clot prevention after hip or knee replacement |
| How it works | Stops the liver using vitamin K to make clotting proteins. | Blocks one key clotting protein directly. |
| Starts working | Full effect takes 3–5 days | 3–4 hours |
| Half-life | 20–60 hours (average ~40) | About 12 hours |
| Typical adult dose | Individual — adjusted to keep INR usually between 2 and 3 (higher for some valves). | AF: 5 mg twice a day (2.5 mg if two of: age ≥80, weight ≤60 kg, poor kidney function). Clot treatment: 10 mg twice a day for 7 days, then 5 mg twice a day. |
| Forms | Tablet (colour-coded strengths) | Tablet |
| Common side effects | Bruising, Nosebleeds, Bleeding gums | Bruising, Nosebleeds, Heavy periods |
| Serious side effects | Major bleeding (blood in urine or stool, vomiting blood, severe headache), Skin necrosis (rare) | Major bleeding, Bleeding in the brain (less than with warfarin) |
| Don't take if | Pregnancy (especially first trimester); Active bleeding or severe bleeding risk; Severe liver disease; Recent major surgery or stroke with bleeding | Active major bleeding; Severe liver disease with clotting abnormalities; Mechanical heart valve; Taking strong CYP3A4 and P-gp inhibitors (ketoconazole, ritonavir) without review |
| Alcohol | Best to limit. Binge drinking changes INR unpredictably and increases bleeding risk; keep intake modest and consistent. | Best to limit. Alcohol raises bleeding risk. |
| Pregnancy | Usually avoidedCauses birth defects in the first trimester; heparin is used instead. | Usually avoidedNot used in pregnancy; low-molecular-weight heparin is preferred. |
| Breastfeeding | Generally considered safeSafe while breastfeeding. | Usually avoidedAvoid. |
| In use since | 1954 | 2012 |
| Brand names | United States: Coumadin, JantovenUnited Kingdom: MarevanIndia: Warf, Uniwarfin | United States: EliquisUnited Kingdom: EliquisIndia: Eliquis, Apigat |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | B01AA03 | B01AF02 |
Taken together
- MajorWarfarin + Apixaban: Double anticoagulation — serious bleeding risk
Two blood thinners together greatly increase the risk of major bleeding.